Related references
Note: Only part of the references are listed.SIRT1 and microRNAs: The role in breast, lung and prostate cancers
Hedyieh Karbasforooshan et al.
EXPERIMENTAL CELL RESEARCH (2018)
SIRT1 and AMPK pathways are essential for the proliferation and survival of primary effusion lymphoma cells
Meilan He et al.
JOURNAL OF PATHOLOGY (2017)
SIRT I gene polymorphisms and risk of lung cancer
Yanbo Lv et al.
CANCER MANAGEMENT AND RESEARCH (2017)
Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas
Ryan D. Morin et al.
CLINICAL CANCER RESEARCH (2016)
Association between functional SIRT1 polymorphisms and the clinical characteristics of patients with autoimmune thyroid disease
Mika Sarumaru et al.
AUTOIMMUNITY (2016)
Mesenchymal stem cells with Sirt1 overexpression suppress breast tumor growth via chemokine-dependent natural killer cells recruitment
Yang Yu et al.
SCIENTIFIC REPORTS (2016)
Association between SIRT1 Gene Polymorphisms and Breast Cancer in Egyptians
Sherine M. Rizk et al.
PLOS ONE (2016)
SIRT1 Polymorphisms Associate with Seasonal Weight Variation, Depressive Disorders, and Diastolic Blood Pressure in the General Population
Leena Kovanen et al.
PLOS ONE (2015)
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
Zheng Zhou et al.
BLOOD (2014)
SIRT1 promoter polymorphisms as clinical modifiers on systemic lupus erythematosus
Camila Rosat Consiglio et al.
MOLECULAR BIOLOGY REPORTS (2014)
Antitumor Effect of SIRT1 Inhibition in Human HCC Tumor Models In Vitro and In Vivo
Simone Portmann et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Nicotinamide Blocks Proliferation and Induces Apoptosis of Chronic Lymphocytic Leukemia Cells through Activation of the p53/miR-34a/SIRT1 Tumor Suppressor Network
Valentina Audrito et al.
CANCER RESEARCH (2011)
Mammalian Sirtuins: Biological Insights and Disease Relevance
Marcia C. Haigis et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
A single-nucleotide variation in a p53-binding site affects nutrient-sensitive human SIRT1 expression
Asma Naqvi et al.
HUMAN MOLECULAR GENETICS (2010)
How does SIRT1 affect metabolism, senescence and cancer?
Christopher L. Brooks et al.
NATURE REVIEWS CANCER (2009)
Mammalian sirtuins - emerging roles in physiology, aging, and calorie restriction
Marcia C. Haigis et al.
GENES & DEVELOPMENT (2006)
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
MF Fraga et al.
NATURE GENETICS (2005)
Histone deacetylases (HDACs): characterization of the classical HDAC family
AJM De Ruijter et al.
BIOCHEMICAL JOURNAL (2003)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Negative control of p53 by Sir2α promotes cell survival under stress
JY Luo et al.
CELL (2001)
hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase
H Vaziri et al.
CELL (2001)
Histone acetylation beyond promoters: long-range acetylation patterns in the chromatin world
EC Forsberg et al.
BIOESSAYS (2001)
Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin
PA Wade
HUMAN MOLECULAR GENETICS (2001)
Histone deacetylases specifically down-regulate p53-dependent gene activation
LJ Juan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
S Imai et al.
NATURE (2000)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
Share Paper
